Abiopharma

Voting Rights and Shares Capital of the Company

New Form 3 - Zymeworks Inc. Filed: 2026-01-13 AccNo: 0001193125-26-011754 Size: 14 KB

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

Munch Mark 🟡 adjusted position in 7.0K shares (1 derivative) of BRUKER CORP (BRKR) at $55.00 Transaction Date: Jan 12, 2026 | Filing ID: 000004

Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

📋 Myles David C. (Officer) plans to sell 50K shares of Olema Pharmaceuticals, Inc. (at $27.60 each, total $1.4M) Filed: Jan 13, 2026 | ID: 000286

Riley Antony A 🟢 acquired 150.0K shares (2 derivative) of Forte Biosciences, Inc. (FBRX) at $29.66 ($2.7M) Transaction Date: Jan 12, 2026 | Filing ID: 000004

📋 Nicholson Nur (Officer) plans to sell 3K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $58K) Filed: Jan 13, 2026 | ID: 000285

Frohning Andrea L. 🟢 acquired 415 shares (1 derivative) of DENTSPLY SIRONA Inc. (XRAY) Transaction Date: Jan 09, 2026 | Filing ID: 000029

(90% Positive) Precision BioSciences (DTIL) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(100% Positive) Cytek Biosciences Inc. (CTKB) Reports Q1 2026 Financial Results

📋 Rodman David Malcom (Officer) plans to sell 8K shares of Mineralys Therapeutics, Inc. (at $32.75 each, total $252K) Filed: Jan 13, 2026 | ID: 000039

Director PFENNIGER RICHARD C JR 🟢 acquired 16.4K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002042

Wagner Paul A. 🟢 acquired 450.0K shares (2 derivative) of Forte Biosciences, Inc. (FBRX) at $29.66 ($8.0M) Transaction Date: Jan 12, 2026 | Filing ID: 000004